Page last updated: 2024-09-03

pentosidine and 8-epi-prostaglandin f2alpha

pentosidine has been researched along with 8-epi-prostaglandin f2alpha in 2 studies

Compound Research Comparison

Studies
(pentosidine)
Trials
(pentosidine)
Recent Studies (post-2010)
(pentosidine)
Studies
(8-epi-prostaglandin f2alpha)
Trials
(8-epi-prostaglandin f2alpha)
Recent Studies (post-2010) (8-epi-prostaglandin f2alpha)
577342051,863248723

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katayama, S1
Durante, A; Monacelli, F; Odetti, P; Poggi, A; Storace, D; Traverso, N; Viviani, GL1

Reviews

1 review(s) available for pentosidine and 8-epi-prostaglandin f2alpha

ArticleYear
[Oxidative stress marker].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arginine; Biomarkers; Deoxyguanosine; Dinoprost; Glycation End Products, Advanced; Humans; Hypertension; Lipid Peroxides; Lipoproteins, LDL; Lysine; Oxidative Stress

2006

Other Studies

1 other study(ies) available for pentosidine and 8-epi-prostaglandin f2alpha

ArticleYear
Effects of valsartan therapy on protein glycoxidation.
    Metabolism: clinical and experimental, 2006, Volume: 55, Issue:12

    Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Arginine; Dinoprost; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Lysine; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Proteins; Tetrazoles; Valine; Valsartan

2006